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Background. Impairments in the attribution of salience are thought to be fundamental to the development of psychotic
symptoms and the onset of psychotic disorders. The aim of the present study was to explore longitudinal alterations in
salience processing in ultra-high-risk subjects for psychosis.
Method. A total of 23 ultra-high-risk subjects and 13 healthy controls underwent functional magnetic resonance imaging
at two time points (mean interval of 17 months) while performing the Salience Attribution Test to assess neural responses
to task-relevant (adaptive salience) and task-irrelevant (aberrant salience) stimulus features.
Results. At presentation, high-risk subjects were less likely than controls to attribute salience to relevant features, and more
likely to attribute salience to irrelevant stimulus features. These behavioural differences were no longer evident at follow-up.
When attributing salience to relevant cue features, ultra-high-risk subjects showed less activation than controls in the ventral
striatumat both baseline and follow-up.Within the high-risk sample, amelioration of abnormal beliefs over the follow-up per-
iodwascorrelatedwithan increase in right ventral striatumactivationduring the attributionof salience to relevant cue features.
Conclusions. Theseﬁndings conﬁrm that salience processing is perturbed in ultra-high-risk subjects for psychosis, that this is
linked to alterations in ventral striatum function, and that clinical outcomes are related to longitudinal changes in ventral stri-
atum function during salience processing.
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Introduction
According to the aberrant salience model of psychosis
(Heinz, 2002; Kapur, 2003; Howes & Murray, 2014),
psychotic symptoms develop as a result of the inappro-
priate assignment of salience to contextually irrelevant
internal and external experiences. This model is sup-
ported by evidence that patients with schizophrenia re-
spond faster to task-irrelevant stimulus features than
healthy controls (HCs) (Pankow et al. 2016), and that
patients with prominent delusions rate irrelevant stim-
uli as more potentially rewarding than patients with-
out delusions (Roiser et al. 2009). This ‘aberrant’
attribution of salience is also evident in people at
ultra-high risk (UHR) for psychosis, who are more
likely to attribute salience to irrelevant stimulus
features than HCs, with this tendency again related
to the severity of abnormal beliefs (Roiser et al. 2013).
Experiments in animals suggest that stimuli become
motivationally salient when the release of dopamine in
the striatum coincides with their perception (Schultz
et al. 1997; Kapur, 2003). In healthy individuals, aber-
rant salience measures are positively associated with
ventral striatal (VS) presynaptic dopamine levels
(Boehme et al. 2015). Dopamine function in the stri-
atum is abnormally elevated in both schizophrenia
(Reith et al. 1994; Laruelle et al. 1996; Breier et al.
1997; Laruelle et al. 1999; Abi-Dargham et al. 2000;
Kumakura et al. 2007; Howes & Kapur, 2009; Howes
et al. 2012) and UHR subjects (Howes et al. 2009b,
2011a, b; Egerton et al. 2013; Mizrahi et al. 2014) and
the aberrant salience hypothesis proposes that this
causes attribution of salience to irrelevant stimuli
(Heinz & Schlagenhauf, 2010; Winton-Brown et al.
2014). In addition, it has been hypothesized that be-
cause dopaminergic neurons may show more
burst ﬁring in psychosis (Goto & Grace, 2005;
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Winton-Brown et al. 2014) the normal phasic dopamin-
ergic response to relevant stimuli may become relative-
ly diminished due to the high level of noise in the
system (Heinz, 2002; Kapur, 2003; Howes et al.
2009a). Psychosis may thus be associated with a
reduced attribution of salience to relevant stimuli as
well as increased attribution of salience to irrelevant
stimuli. This is consistent with data from recent studies
in UHR subjects and in patients with psychosis, which
report impairments in both forms of salience process-
ing (Roiser et al. 2009, 2013, Pankow et al. 2016).
Data from functional neuroimaging studies suggest
that UHR subjects and patients with psychosis show
altered activation in the VS during tasks that engage
motivational salience processing. A recent meta-
analysis suggested that reduced VS responses occur
in patients with schizophrenia spectrum disorders rela-
tive to controls during the processing of contextually
relevant information and that left VS hypoactivation
was more severe in patients with high scores of nega-
tive symptoms (Radua et al. 2015). The relationship be-
tween VS activation during reward prediction and
positive symptoms requires further investigation be-
cause only six studies were available (Simon et al.
2010; Esslinger et al. 2012; Nielsen et al. 2012a; Roiser
et al. 2013; Wotruba et al. 2014; de Leeuw et al. 2015)
and there was residual heterogeneity among them
(Radua et al. 2015). Interestingly, individual treatment
with antipsychotics was associated with a normaliza-
tion of VS activation during reward prediction, and
this improvement was associated with the improve-
ment of positive symptoms (Nielsen et al. 2012b).
With respect to contextually irrelevant information, it
has been shown that striatal activation during incorrect
distracter trials was positively correlated with aberrant
salience symptoms in schizophrenia patients (Ceaser &
Barch, 2015). In UHR subjects, the VS response to ir-
relevant stimulus features was found to be associated
with the severity of abnormal beliefs (Roiser et al.
2013). However, it is not known if altered VS activation
during salience processing normalizes in UHR indivi-
duals whose psychotic symptoms have remitted.
The Salience Attribution Test (SAT) is a paradigm
that can be used to assess task-relevant and task-
irrelevant motivational salience responses, termed
adaptive and aberrant salience, respectively (Roiser
et al. 2009, 2010). Our objective was to assess the rela-
tionship between changes in clinical features in a
UHR cohort and longitudinal changes in VS activation
elicited during the SAT paradigm. Our ﬁrst hypothesis
was that at clinical presentation, UHR subjects would
show increased aberrant but reduced adaptive salience
processing compared with HCs, and that these differ-
ences would be associated with concomitant altera-
tions in VS activation. Our second hypothesis was
that clinical improvements the UHR subjects subse-
quent to presentation would be associated with a lon-
gitudinal normalization of behavioural and neural
responses during salience processing.
Method
Participants
A total of 29 individuals who met the Comprehensive
Assessment of At-Risk Mental States (CAARMS)
(Yung et al. 2005) criteria for the UHR state were
recruited from Outreach and Support in South
London (OASIS; Fusar-Poli et al. 2013b), a clinical ser-
vice for people at high risk for psychosis. According
to international standard UHR criteria (for a compre-
hensive review, see Fusar-Poli et al. 2013a), inclusion
required the presence of one or more of the following:
(i) presence of attenuated psychosis symptoms (APS);
(ii) genetic risk and deterioration syndrome (GRD);
or (iii) brief limited and intermittent psychotic symp-
toms (BLIPS). In all, 24 individuals were included
based on APS, three based on BLIPS and two based on
APS +GRD. Following presentation, all subjects were
provided with clinical care from OASIS (Fusar-Poli et al.
2013b). Three subjects received antipsychotic medication
andwere thus excluded fromtheanalysis.Of the subjects,
26 also received cognitive–behavioural therapy (CBT),
which at the time of writing had been completed in
nine subjects (26 sessions on average, range 14–65). Of
the subjects, seven received low-dose antidepressants:
ﬁve citalopram (3 × 20, 1 × 40 mg, and 1 × unknown
dose), one mirtazapine (dose unknown) and one sertra-
line (100 mg). The speciﬁc treatments offered by OASIS
have been detailed elsewhere (Fusar-Poli et al. 2015). All
subjects were managed in the community, attending
regular out-patient appointments.
A total of15HCs fromthe samegeographical areawere
recruitedvia local advertisements.Absenceof psychiatric
illness historywas conﬁrmedwith theMini International
Neuropsychiatric Inventory (Sheehan et al. 1998).Noneof
the HC subjects had a history of neurological illness, or
Diagnostic and Statistical Manual of Mental Disorders,
4th edition (DSM-IV) drug or alcohol dependence
(American Psychiatric Association, 2013). All subjects
provided informed written consent to participate and
the study was approved by the local National Health
Service Research Ethics Committee.
The SAT
The SAT has been previously described in detail else-
where (Roiser et al. 2009, 2010). In brief, the SAT is a
speeded-response game, rewarded with money,
which measures responses to cue features, which can
be either task-relevant or task-irrelevant. On each
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trial of the task, participants were required to respond
to a brieﬂy presented square. Before the square
appeared, a cue was shown indicating the likelihood
of obtaining a reward for the forthcoming response.
Participants received a monetary reward on 50% of
trials, with more money awarded for faster responses.
The cues varied in two different visual dimensions; col-
our (red or blue) and shape (animals or household
objects). One of these cue dimensions was task-relevant
and the other task-irrelevant. One task-relevant feature
was highly associated with receiving a reward, with
87.5% of these trial types rewarded (e.g. blue stimuli).
The other task-relevant dimension (e.g. red stimuli)
was not rewarded on any trials. For the task-irrelevant
dimension, an equal proportion of both features
(e.g. animal and household stimuli) was rewarded.
Participants were not informed about these contingen-
cies, which remained the same over the two blocks of
64 trials within a testing session, and instead had to
learn them over successive trials of the task. To avoid
practice effects between baseline and follow-up, four
different versions of the task were used, counterba-
lanced across participants, each with a different stimu-
lus feature (blue, red, animal or household) rewarded
with high probability.
Participants performed the task on two occasions,
while being scanned using functional magnetic reson-
ance imaging (fMRI). The baseline assessment was per-
formed at the time of clinical presentation. The
follow-up assessment was carried out approximately
17 months later. On each visit they performed the
same version of the task twice. The SAT provides be-
havioural measures of adaptive (relevant) and aberrant
(irrelevant) motivational salience on the basis of reac-
tion times (RTs: implicit salience) and visual analogue
scale (VAS) ratings from 0 to 100% (explicit salience).
Implicit adaptive salience is deﬁned as the speeding
of responses on high- relative to low-probability re-
ward trials. Explicit adaptive salience is deﬁned as
the increase in VAS ratings on high- relative to low-
probability reward trials. Implicit aberrant salience
and explicit aberrant salience are deﬁned as the abso-
lute difference in RT and VAS ratings, respectively, be-
tween the two levels of the task-irrelevant stimulus
dimension (Roiser et al. 2009).
Behavioural analysis
Behavioural scores on the SAT were analysed using a
repeated-measures analysis of variance (ANOVA)
with time as within-subject and group as between-
subject factors and years of education as a covariate.
To test for group differences at baseline and follow-up
separately, univariate ANOVA with education as cov-
ariate was used. Using box-and-whisker plots on each
SAT measure for both groups separately, two HCs and
two UHR subjects were excluded as outliers.
fMRI data acquisition and analysis
Scanning was performed on a whole-body 3 T MRI
General Electric (USA) system. During each of the
four scanning runs (two per day), we acquired
T2*-weighted echo-planar images (EPIs) with the fol-
lowing parameters: 50 axial slices (sequential and top-
down acquisition) of 2.4 mm thickness, 2.7 mm inter-
slice gap, ﬁeld of view 240 mm2 and matrix size 64 ×
64. The repetition time was 2.5 s and the echo time
25 ms. A total of 237 image volumes were acquired
in a single functional run.
EPIswere analysed using an event-related designwith
SPM12 (www.ﬁl.ion.ucl.ac.uk/spm). Pre-processing was
performed for each subject and time point separately. In
brief, slice-timing correction was ﬁrst performed on
each volume using the middle slice as the reference. The
imageswere then realigned to theﬁrst image in the series
(following removal of dummy scans), spatially normal-
ized to the Montreal Neurological Institute (MNI) tem-
plate and smoothed with a Gaussian kernel of 8 mm
full half-width maximum (FWHM). All images under-
went visual inspection andparticipantswith a highnum-
ber of severely corrupted images and/or gross artefacts
were excluded (two HCs and one UHR). Additionally,
all images were checked for movement artefacts, and all
scans with more than 5 mm deviation from the previous
scan in any dimension, resulting in corrupted volumes,
were excluded and replaced with the average of the
neighbouring volumes (5.1% in HCs and 1.5% in
UHRs). Subjects withmore than 10% corrupted volumes
were excluded (twoUHRs). In theﬁnal sampleof 23UHR
subjects, 19 subjects were included based on BLIPS, three
based on BLIPS and one based on APS +GRD.
Voxel-wise maximum likelihood parameter esti-
mates were calculated during the ﬁrst-level analysis
using the general linear model. Our design matrix
included an autoregressive AR(1) model of serial corre-
lations and a high-pass ﬁlter with a cut-off of 128 s. The
onsets of each event were convolved with the SPM
synthetic haemodynamic response function. In this
model, we included four ‘cue’ regressors, representing
the different cue types and an ‘outcome’ regressor
representing the time points when reward feedback
was provided during the task. Cues on which partici-
pants failed to respond entirely were excluded from
the analysis (regressor of no interest) due to the possi-
bility that participants were not attending during the
trial. Eight contrast images were generated per partici-
pant: adaptive and aberrant reward prediction at base-
line and follow-up separately; average images over
both visits for adaptive and aberrant reward prediction
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(to test for main effect of group); and two images sub-
tracting the contrast vector of baseline from follow-up
(to test for the main effect of time and time x group
interaction). Adaptive reward prediction contrasts
were deﬁned as: high-probability reward cue features
minus low-probability reward cue features across the
task-relevant dimension. Aberrant reward prediction
contrasts were deﬁned as subjective ‘high-probability’
reward cue features minus subjective ‘low-probability’
reward cue features (based on the subject’s VAS ratings
for that run) across the task-irrelevant dimension
(Roiser et al. 2010).
Two-sample tests were conducted at the second level
to test for group effects at baseline and follow-up sep-
arately, as well as to test for main effects of group and
time and for time x group interactions. Signiﬁcance
was assessed at a cluster-level threshold of p < 0.05
family-wise error (FWE) corrected across the whole
brain, using an uncorrected cluster-forming threshold
of p < 0.001 (Petersson et al. 1999; Woo et al. 2014)
with an extent threshold of 20 voxels. We also focused
our analysis on the VS as this was part of our primary
hypothesis, using a voxel-level approach. The VS re-
gion of interest was deﬁned using coordinates taken
from a previous SAT fMRI study in an independent
UHR cohort (Roiser et al. 2013): right (x = 12; y = 12;
z =−3) and left (x =−12; y = 9; z =−3). Small volume
correction was applied for this analysis using 15 mm
spheres around these coordinates (Roiser et al. 2013)
and a voxel-level threshold of p < 0.05 FWE corrected
was considered signiﬁcant. As groups differed in
years of education, this variable was added as a covari-
ate in the second-level model.
Relationships between brain activation, behaviour
and symptoms
Relationships between neural responses and behav-
ioural and clinical features were identiﬁed by includ-
ing outcome measures from the SAT, CAARMS and
Global Assessment of Functioning (GAF) as covariates
in second-level models. The same procedure for correc-
tion for multiple comparisons as described above was
employed. Relationships between behavioural salience
responses and symptomatology in UHR subjects were
tested with Pearson’s correlation coefﬁcients using the
Statistical Package for the Social Sciences (SPSS 16,
SPSS Inc., USA).
Results
Demographical and clinical features
The two groups did not differ in age, gender, handed-
ness, intelligence quotient or cigarette, alcohol, canna-
bis and cocaine consumption, but HCs had more
years of education (therefore, all group comparisons
were covaried for years of education). At baseline,
UHR subjects had higher scores on CAARMS positive
and negative symptoms and lower scores on the
GAF. Over time, the UHR group showed signiﬁcant
improvements in CAARMS positive and negative
symptoms, but not in GAF scores (Table 1).
Behavioural data
Aberrant attribution of salience
Across both visits, UHR subjects showed signiﬁcantly
higher implicit aberrant salience than HC subjects
(F1,34 = 6.718, p = 0.014), and there was a trend for a
group × time interaction (F1,34 = 3.225, p = 0.081). There
was also a trend for a group × time interaction for expli-
cit aberrant salience (F1,34 = 3.325, p = 0.077). Based on
our a priori hypotheses we constructed linear contrasts
at each time point to test for the predicted group differ-
ences in aberrant salience.
At baseline, UHR subjects were more likely than
HCs to attribute salience to irrelevant cue features (ex-
plicit aberrant salience) (F1,34 = 4.732, p = 0.037), but did
not exhibit greater implicit aberrant salience than HCs
(F1,34 = 0.964, p = 0.333). At follow-up the group differ-
ence in explicit aberrant salience was no longer signiﬁ-
cant (F1,34 = 0.061, p = 0.806), but HCs had signiﬁcantly
lower implicit aberrant scores than the UHR group
(F1,34 = 12.296, p = 0.001) due to a reduction in this
measure over time (Figs. 1a and b).
Within the UHR group we detected no signiﬁcant
correlations between aberrant salience responses and
psychotic symptoms (baseline, follow-up, change
over time).
Adaptive attribution of salience
Across both visits, the UHR group had lower implicit
adaptive salience scores than HCs (F1,34 = 11.472, p =
0.002), as well as lower explicit adaptive salience scores
(F1,34 = 5.493, p = 0.035). There was also a signiﬁcant
group x time interaction for explicit adaptive salience
(F1,34 = 4.157, p = 0.049).
At baseline, UHR subjects had signiﬁcantly lower
implicit adaptive salience than HCs (F1,34 = 13.866, p =
0.001) and also exhibited signiﬁcantly lower explicit
adaptive salience (F1,34 = 9.043, p = 0.005). Both of
these group differences were no longer signiﬁcant at
follow-up (implicit adaptive salience: F1,34 = 3.733, p =
0.062; explicit adaptive salience: F1,34 = 1.360, p =
0.252), due to improved scores in the UHR group to-
gether with relatively stable performance in HCs
(Figs. 2a and b).
Within the UHR group, explicit adaptive salience
scores at follow-up were negatively correlated with
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Table 1. Demographical and clinical characteristics of the study sample
Healthy controls (n = 13) Ultra-high-risk subjects (n = 23) Group statistics
At baseline
Mean age, years (S.D.) [range] 24.38 (5.32) [20–36] 21.57 (3.55) [18–29] t34 = 1.709, p = 0.104
a
Female/male, n 3/10 11/12 χ2 = 2.141, p = 0.143a
Handedness, right/left, n 11/2 22/1 χ2 = 1.324, p = 0.250a
Mean duration of education, years (S.D.) 14.77 (1.64) 12.52 (2.25) t34 = 3.436, p = 0.002
a
Mean NART FSIQ (S.D.) 111.50 (6.10) 107.04 (9.07) t34 = 1.578, p = 0.124
a
Mean number of cigarettes, per day (S.D.) 2.69 (4.38) 5.57 (8.13) t34 = 1.376, p = 0.178
a
Mean number of alcohol units, per week (S.D.) 11 (10.52) 6.87 (9.28) t34 = 1.179, p = 0.251
a
Cannabis consumption, yes/no, n 8/5 14/9 χ2 = 0.002, p = 0.0968a
Cocaine consumption, yes/no, n 4/9 8/15 χ2 = 0.060, p = 0.806a
Mean GAF (S.D.) 84.15 (4.88) 59.74 (7.61) t34 = 11.706, p < 0.001
a
Mean CAARMS positive symptoms (S.D.)c 0.54 (1.20) 7.65 (3.81) t34 =−8.262, p < 0.001a
Mean CAARMS negative symptoms (S.D.)c 0.17 (0.58) 6.39 (3.29) t34 =−7.025, p < 0.001a
At follow-up
Mean age, years (S.D.) [range] 25.70 (5.33) [21–37] 22.96 (3.48) [19–30] t34 = 1.668, p = 0.113
a
Mean number of cigarettes, per day (S.D.) – 3.13 (5.65) t22 = 1.611, p = 0.121
b
Mean number of alcohol units, per week (S.D.) – 7.74 (10.82) t22 = 0.506, p = 0.618
b
Cannabis consumption, yes/no, n – 14/9 χ2 = 0.000, p = 1b
Cocaine consumption, yes/no, n – 8/15 χ2 = 0.000, p = 1b
Mean GAF (S.D.) – 62.39 (15.78) t22 = 0.896, p = 0.38
b
Mean CAARMS positive symptoms (S.D.)c – 5.22 (4.88) t22 = 2.811, p = 0.010
b
Mean CAARMS negative symptoms (S.D.)c – 4.22 (4.35) t17 = 2.663, p = 0.016
b
S.D., Standard deviation; NART FSIQ, National Adult Reading Test full-scale intelligence quotient; GAF, Global Assessment of Functioning; CAARMS, Comprehensive Assessment of
At-Risk Mental States.
a Two-sample t tests and χ2 tests between groups, respectively.
b Paired tests and χ2 tests within ultra-high-risk subjects between baseline and follow-up assessment.
c CAARMS positive symptoms were the sum of severity scores for unusual thought content (abnormal belief), non-bizarre ideas, perceptual abnormalities and disorganized speed;
negative symptoms were the sum of severity scores for alogia, avolition/apathy and anhedonia.
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the severity of abnormal beliefs (r =−0.674, p < 0.001)
(online Supplementary Fig. S1A) and of positive symp-
toms (r =−0.653, p < 0.001) (online Supplementary
Fig. S1B), and positively correlated with the level of
global functioning (r = 0.497, p = 0.014) (online
Supplementary Fig. S1C).
All behavioural results remained after excluding the
UHR subject with a later transition to psychosis (online
Supplementary information 2A).
Activation during salience processing
Aberrant reward prediction
There were no signiﬁcant effects of group or time, and
no group x time interactions. There were also no sign-
iﬁcant group differences in responses to irrelevant cues
at either baseline or follow-up.
Adaptive reward prediction
Across both time points, UHR subjects showed less ac-
tivation than HCs in the VS, calcarine sulcus and
midbrain bilaterally and in the left cuneus and middle
temporal gyrus (main effect of group: Fig. 3a, online
Supplementary Table S1). Across both groups, activa-
tion during adaptive reward prediction was greater at
follow-up than at baseline in the bilateral VS and
right thalamus (main effect of time: Fig. 3b, online
Supplementary Table S2). No signiﬁcant group × time
interactions were found for adaptive reward prediction.
At baseline, the UHR group showed signiﬁcantly
less activation than HCs in the VS bilaterally and the
left parahippocampal and middle temporal gyrus,
and cerebellum during adaptive reward prediction
(online Supplementary Table S3). At follow-up, the
UHR group continued to show signiﬁcantly less acti-
vation in the VS bilaterally (online Supplementary
Table S4). All results remained after excluding the
UHR subject with a later transition to psychosis (online
Supplementary information S2B).
There were no signiﬁcant relationships between
neural responses from the aberrant and adaptive re-
ward prediction contrast and behavioural scores on
the SAT (baseline, follow-up, change over time).
Fig. 1. (a) Implicit (reaction times, ms) and (b) explicit
(visual analogue scale) scores for aberrant motivational
salience processing in healthy controls and subjects at
ultra-high risk (UHR) for psychosis. Values are means, with
standard errors represented by vertical bars.
Fig. 2. (a) Implicit (reaction times, ms) and (b) explicit
(visual analogue scale) scores for adaptive motivational
salience processing in healthy controls and subjects at
ultra-high risk (UHR) for psychosis. Values are means, with
standard errors represented by vertical bars.
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Relationship between longitudinal changes in
clinical features and brain activation
Aberrant salience
There were no signiﬁcant relationships between
changes in clinical features and longitudinal changes
in brain activation during aberrant reward prediction.
Adaptive salience
In the UHR group, there was a trend (t22 = 1.775, p =
0.09) for the mean severity of abnormal beliefs to im-
prove between presentation and follow-up (Fig. 4a).
The degree of improvement in abnormal beliefs over
time was associated with the longitudinal increase in
activation during adaptive reward prediction in the
right VS and in the supplementary motor cortex bilat-
erally (Figs. 4b and c, online Supplementary Table S5).
This relationship remained after excluding the UHR
subject with a later transition to psychosis (online
Supplementary information S2B).
There were no signiﬁcant correlations between longi-
tudinal changes in negative symptoms and in neural
responses during motivational salience processing.
Discussion
To our knowledge, this is the ﬁrst longitudinal investi-
gation of salience processing in subjects with psychotic
symptoms. We explored the relationship between
changes in the clinical features of people at UHR for
psychosis after they had presented to clinical services
and longitudinal changes in their behavioural and
neural responses during aberrant and adaptive sali-
ence processing.
Aberrant salience
Consistent with the aberrant salience model (Heinz,
2002; Kapur, 2003; Howes & Kapur, 2009), we found
that UHR subjects were more likely to attribute sali-
ence to irrelevant stimuli than HCs at clinical presenta-
tion. These data are consistent with a previous report
of increased explicit aberrant salience in an independ-
ent UHR sample (Roiser et al. 2013). A study using
the SAT in ﬁrst-episode schizophrenia did not ﬁnd a
difference in the patient sample overall, but found
that aberrant salience was related to the severity of
delusions and negative symptoms within the patient
group (Roiser et al. 2009). However, it should be
noted that another study found no signiﬁcant differ-
ences between UHR subjects, ﬁrst-episode patients
and controls in aberrant salience attribution
(Smieskova et al. 2015).
During the 17-month follow-up period, there was a
reduction in explicit aberrant salience in UHR subjects,
such that there was no longer a signiﬁcant group dif-
ference relative to HCs. On the basis that abnormal
Fig. 3. (a) Greater activation during adaptive reward prediction in healthy controls (HC) compared with ultra-high-risk
(UHR) subjects across both visits. (b) Greater activation at follow-up relative to baseline during adaptive reward prediction
across both groups. Images are displayed at a cluster-forming threshold of p < 0.001 uncorrected, with an extent threshold of
20 voxels. Colour bars indicate t values.
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salience processing is proposed to underlie the gener-
ation of psychotic symptoms (Roiser et al. 2009,
2013), we tested whether longitudinal changes in aber-
rant salience processing were related to changes in clin-
ical features in the UHR subjects during the follow-up
period. Although UHR subjects showed improvements
clinically, there were no signiﬁcant correlations be-
tween changes in these variables and longitudinal
changes in behavioural measures of aberrant salience
processing. It has been proposed that the link between
aberrant salience and symptoms is moderated by cog-
nitive biases (Howes & Murray, 2014), which may ac-
count for the lack of direct relationship between
aberrant salience and symptom change in our data.
Adaptive salience
The aberrant salience model proposed that adaptive
salience is intact in patients with psychosis, but may
become impaired as a result of treatment with anti-
psychotic medication (Heinz, 2002; Kapur, 2003). The
ﬁrst experimental study of salience processing in
ﬁrst-episode psychosis using the SAT found that
patients showed impaired adaptive salience, and this
was attributed to be an effect of antipsychotic treat-
ment (Roiser et al. 2009). However, a subsequent
study of largely medication-naive UHR subjects also
found a trend for reduced implicit adaptive salience
(Roiser et al. 2013). In the present study, which
involved a larger patient sample, at presentation,
UHR subjects showed signiﬁcantly reduced adaptive
salience responses. As all of our UHR subjects were
naive to antipsychotic medication at this stage, these
data not only suggest that adaptive salience is
impaired in UHR subjects, but that this is not second-
ary to antipsychotic treatment. Consistent with this in-
terpretation, a recent study found that adaptive
salience processing was numerically (though not sign-
iﬁcantly) impaired in ﬁrst-episode psychosis patients,
but this impairment was if anything less marked in
antipsychotic-treated than untreated patients
(Smieskova et al. 2015).
Although signiﬁcant behavioural differences in
adaptive salience processing were only present at
Fig. 4. (a) Unusual thought content (abnormal beliefs) at baseline (mean: 3.04) and follow-up (mean: 2.09) in ultra-high-risk
(UHR) subjects (t22 = 1.775, p = 0.09). (b) Negative correlation between changes in brain activation during adaptive reward
prediction and changes in abnormal beliefs from baseline to follow-up in UHR subjects. The image is displayed at a
cluster-forming threshold of p < 0.001 uncorrected, with an extent threshold of 20 voxels. The colour bar indicates t values.
(c) Scatterplot of negative relationship between change in right ventral striatum (VS) activation during adaptive salience
processing, taken from the peak voxel in (b) and change in abnormal beliefs [Comprehensive Assessment of At-Risk Mental
States (CAARMS) item unusual thought content] from baseline to follow-up in UHR subjects (r =−0.702).
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baseline, group differences in activation during adap-
tive salience processing were seen at both presentation
and follow-up time points. At both time points, UHR
subjects showed reduced activation relative to HCs in
the VS. This is consistent with a recent meta-analysis
demonstrating reduced VS activity in response to
reward-predicting cues in schizophrenia spectrum dis-
orders (Radua et al. 2015), and reports of altered VS ac-
tivation in patients with psychosis during reward
prediction error tasks (Murray et al. 2008; Gradin
et al. 2011). Furthermore, within the UHR group, im-
provement in abnormal beliefs over the follow-up per-
iod was correlated with the degree to which VS
activation increased over time during adaptive reward
prediction. This ﬁnding is in line with data from unme-
dicated ﬁrst-episode patients demonstrating a negative
correlation between the severity of delusional symp-
toms and reward prediction signals in the VS
(Esslinger et al. 2012). Taken with longitudinal positron
emission tomography imaging ﬁndings that changes in
dopamine synthesis capacity in the dorsal (associative)
striatum are associated with change in clinical state
(Howes et al. 2011a), our ﬁndings suggest that altera-
tions in both the VS and dorsal striatum are linked to
symptom change. A possible mechanism could be
that hyperactive inputs from the hippocampus to the
VS in psychosis may have an impact on dopaminergic
neurons that project to more dorsal (associative) striat-
al areas and thereby affect dorsal striatum-related sali-
ence processing (Haber, 2003; Lodge & Grace, 2011,
2012; Modinos et al. 2015).
The amelioration of abnormal beliefs in UHR sub-
jects was also associated with longitudinal increases
in activation in the supplementary motor cortex to re-
ward predicting cue features. The latter ﬁnding was
not predicted, as the supplementary motor cortex is
not speciﬁcally implicated in motivational salience pro-
cessing. However, the SAT is a complex task that also
involves sustained attention, maintaining stimulus in-
formation in memory, decision-making and response
selection (Roiser et al. 2013), and the UHR state is asso-
ciated with a broad range of cognitive impairments
(Fusar-Poli et al. 2012). We therefore speculate that this
ﬁnding in the supplementary motor cortex may be
related to alterations in one or more of these processes,
possibly secondary to changes in striatal function.
Furthermore, UHR subjects also showed reduced activa-
tion in the calcarine sulcus, cuneus,midbrain andmiddle
temporal gyrusacrossbothvisitsduring theattributionof
salience to relevant stimuli, as well as reduced activation
in the parahippocampal gyrus, cerebellum, midbrain,
middle temporal gyrus, middle and anterior cingulate
cortex, inferior frontal gyrus and insula at baseline and/
or follow-up (see online Supplementary information S1
and S2B for more details). Together with the striatum,
integration of these regions is important to sustain emo-
tion and cognition, especially during the detection and
processing of salient information (Seeley et al. 2007;
Menon & Uddin, 2010). Dysfunction of this network
and abnormal network switching when dealing with a
relevant task at hand has been proposed to underlie the
formation of psychotic symptoms (Palaniyappan &
Liddle, 2012;Palaniyappan et al.2013; Schmidt et al.2016).
Some limitations of our study merit comment. The
sample sizes were modest, largely because inclusion
required that participants completed multi-modal neu-
roimaging assessments at both baseline and follow-up.
The modest group sizes may thus have accounted for
the absence of signiﬁcant group differences in activa-
tion during aberrant salience processing. A further
consideration is that at the time of writing, only one
UHR subject had developed a psychotic disorder (all
results remained after excluding this subject; see
Supplementary information S2A and B for details),
precluding any examination of the relationship be-
tween abnormal salience processing and the risk of
transition to psychosis. In this regard, it is possible
that the low conversion rate in our UHR sample may
explain the lack of alterations in brain activation dur-
ing aberrant salience processing. Future large-scale
studies with a meaningful ratio between converters
and non-converters are required to test if functional
brain alterations during aberrant reward prediction
are evident in UHR subjects who later develop psych-
osis or if the risk of transition to psychosis is more
related to impaired activation when dealing with a
relevant task at hand (i.e. adaptive reward prediction).
Furthermore, in accordance with the aberrant salience
model (Kapur, 2003), the SAT has been designed to
measure abnormal motivational (reward) salience pro-
cessing in psychosis and its relation to dopamine dys-
regulation in the VS. However, motivation is not the
only form of salience (Winton-Brown et al. 2014), and
it would be important to test ventral and dorsal (asso-
ciative) striatal activation in psychosis during other
forms of salience processing that are not measured
using speeded response tasks. Finally, subsequent to
presentation, some of the UHR subjects received CBT
or low doses of antidepressants, which may have
inﬂuenced our ﬁndings. In this study, the numbers of
subjects receiving different forms of treatment were
too small to allow for meaningful subgroup analyses
and this issue would be better addressed in longitudin-
al studies that were explicitly linked to a clinical trial of
an intervention that might be expected to improve mo-
tivational salience processing.
In summary, this study shows that UHR subjects ex-
hibit behavioural deﬁcits in both adaptive and aberrant
salience processing at clinical presentation, which dis-
appeared along with the remission of APS over the
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follow-up period. Our results further indicate VS
hypoactivation in UHR subjects during adaptive re-
ward prediction at baseline and follow-up and that
the amelioration of abnormal beliefs over the follow-up
period is linked to a longitudinal increase in VS activa-
tion during adaptive reward prediction.
Supplementary material
The supplementary material for this article can be
found at http://dx.doi.org/10.1017/S0033291716002439
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